Abcam plc logo
Abcam plc ABCM

Geschäftsbericht 2022
hinzugefügt 28.12.2024

report update icon

Abcam plc Gesamtverbindlichkeiten 2011-2026 | ABCM

Gesamtverbindlichkeiten Jährlich Abcam plc

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
330 M 345 M 190 M 61.9 M 63.1 M 54.6 M 68.4 M 35.8 M 25.7 M 29.6 M 27.6 M 12.6 M

Alle Zahlen in GBP-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
345 M 12.6 M 104 M

Gesamtverbindlichkeiten Vierteljährlich Abcam plc

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - 330 M - - - 190 M - 308 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in GBP-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
330 M 190 M 276 M

Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Gesamtverbindlichkeiten Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
1.98 B - 2.43 % $ 254 M germanyGermany
Advaxis Advaxis
ADXS
7.89 M - -9.65 % $ 45.9 M usaUSA
Akouos Akouos
AKUS
45.1 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
74.8 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
42.9 M - 4.14 % $ 49.1 M usaUSA
I-Mab I-Mab
IMAB
707 M - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
62.5 M - - $ 1.01 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
6.77 M - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
6.45 B - - $ 40.3 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
46.6 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
72 M - - $ 8.42 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.9 M $ 0.88 -2.05 % $ 6.47 M chinaChina
Biophytis SA Biophytis SA
BPTS
20.4 M - -13.47 % $ 169 M franceFrance
Genfit SA Genfit SA
GNFT
215 M - 2.54 % $ 160 B franceFrance
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
455 M $ 22.46 0.72 % $ 3.72 B usaUSA
Aptinyx Aptinyx
APTX
28.4 M - -39.0 % $ 4.57 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
8.16 M - -1.52 % $ 24.7 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.43 M - - $ 7.46 M israelIsrael
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
11 M - -2.5 % $ 5.88 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
137 M - -4.8 % $ 255 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
43.5 M - 1.93 % $ 17.4 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
11.1 M - -3.03 % $ 260 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
30.3 M - - $ 35.4 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
1.1 B - - - russiaRussia
ChromaDex Corporation ChromaDex Corporation
CDXC
29.9 M - -0.88 % $ 598 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
17.6 M - 5.93 % $ 314 M canadaCanada
Galectin Therapeutics Galectin Therapeutics
GALT
146 M $ 2.32 -2.32 % $ 148 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
6.99 M - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
51.5 M - -13.39 % $ 1.45 M usaUSA
Genmab A/S Genmab A/S
GMAB
2.02 B $ 26.78 0.53 % $ 16.8 B danmarkDanmark
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
38.9 M - 17.91 % $ 11.1 M usaUSA
BioNTech SE BioNTech SE
BNTX
2.76 B $ 100.91 -1.13 % $ 27.2 B germanyGermany
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
20.1 M - - $ 169 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
1.1 M - -52.27 % $ 4.45 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
37.2 M - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
194 M $ 4.08 -0.61 % $ 436 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
243 M $ 23.06 -1.54 % $ 2.93 B usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
242 M $ 1.22 2.1 % $ 203 M usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
15.5 M $ 8.34 1.07 % $ 75.3 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
411 M $ 1.49 4.58 % $ 397 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
37.2 M - -45.71 % $ 1.2 M canadaCanada
AstraZeneca PLC AstraZeneca PLC
AZN
65.4 B - - $ 96.9 B britainBritain
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Innate Pharma S.A. Innate Pharma S.A.
IPHA
151 M $ 1.41 0.71 % $ 235 M franceFrance
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
3.45 M $ 2.92 -0.14 % $ 4.81 M israelIsrael
Inventiva S.A. Inventiva S.A.
IVA
226 M $ 5.04 -1.75 % $ 138 M franceFrance
BeiGene, Ltd. BeiGene, Ltd.
BGNE
3.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Akero Therapeutics Akero Therapeutics
AKRO
75.8 M - - $ 3.67 B usaUSA
bluebird bio bluebird bio
BLUE
425 M - - $ 546 M usaUSA